India's $200M Pharma Opportunity in Afghanistan
Border tensions between Afghanistan and Pakistan open a major pharmaceutical export window for India. Explore how Indian generics are filling critical shortages and strengthening regional ties.
Border tensions between Afghanistan and Pakistan open a major pharmaceutical export window for India. Explore how Indian generics are filling critical shortages and strengthening regional ties.
A Vadodara scholar's patented formulation for Bortezomib and Pemetrexed extends shelf life, retains 99% potency, and promises wider access in challenging climates. Read about this healthcare innovation.
Facing 50% US tariffs, India aggressively pursues new trade pacts with UK, EU, and others to diversify exports and safeguard its manufacturing ambitions. Explore the strategy and key deals.
Get the latest live updates from across India. Stay informed on breaking news, political developments, economic shifts, and major events shaping the nation today.
PGI Chandigarh vigilance uncovers Rs 15 crore scandal involving missing pharmacy bills. Probe suspects deliberate destruction to hide fraud in Ayushman Bharat schemes. Read the shocking details.
BMW Group India achieves its highest-ever annual car sales in 2025, selling 18,001 units. Electric vehicle sales skyrocket by 200%, contributing 21% to total sales. Read the full analysis.
India's exports to China surged 33% to $12.22 billion from April-November 2024-25, driven by electronics, agriculture, and metals. This marks a structural shift as trade with the US faces high tariffs. Read more.
A Bengaluru Redditor exposed a pharmacy allegedly charging double. The incident highlights why you must always check your bill. Read to protect yourself from such scams.
GSHSEB extends GUJCET 2026 application deadline to Jan 16 with a Rs 1,000 late fee. Exam scheduled for March 29 for engineering and pharmacy admissions. Apply now at gujcet.gseb.org.
Natco Pharma files suit in Delhi High Court seeking revocation of Novo Nordisk's patent on diabetes drug semaglutide. Court issues notice, hearing set for Feb 5. Indian pharma race for generic Ozempic heats up.
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Japanese giants like MUFG, Nidec, and Polyplastics are setting up tech centres in India. Driven by an ageing population and China risk, they aim to tap India's deep talent pool for AI, cybersecurity, and engineering. Read more.
New Zealand PM Christopher Luxon hails the historic Free Trade Agreement with India as a major boost for jobs, exports, and economic growth. Key details inside.
The GSEB closes GUJCET 2026 registration today, Jan 6, 2026. Apply now for engineering, diploma & pharmacy courses in Gujarat. Exam on March 29.
India plans a new wholesale licensing system for bulk drugs and a supplier database to enhance traceability and accountability in its $50-billion pharmaceutical market, following global safety concerns.
Nxtcell India appoints Atul Vivek as CEO effective Jan 1, 2026. With 20 years of leadership experience from Realme, Samsung, and others, he will drive Alcatel's smartphone and AIoT expansion. Read more.
Shark Tank India Season 5 premieres Jan 5, 2026, with new sharks joining the panel. Get all details on judges, timing, and where to watch the business reality show.
A citizen-funded study finds generic medicines, including Jan Aushadhi, match quality of expensive brands. Experts urge trust in affordable options for better treatment adherence. #Healthcare #India
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
Bangladesh's Rapid Action Battalion arrests three key suspects in the brutal murder of pharmacy owner Khokon Chandra Das. Details on the investigation and the shocking attack.
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
GLP-1 weight-loss drugs, despite limited uptake, topped India's pharma sales by value in 2025. With generics and new approvals coming, 2026 promises wider access. Plus, government plans 200+ Day Care Cancer Centres. Read the full analysis.
Indian companies plan a major hiring surge in 2026, creating 10-12 million jobs. Driven by tech and diversity goals, firms like EY, Tata Motors, and Diageo are expanding teams. Read the full outlook.
India's auto sector ended 2025 with robust growth. JSW MG, Mahindra, Kia & Skoda reported record sales, driven by EVs and strong demand. Get all the key figures and insights here.
From preventive screenings to affordable generics, 2025 reshaped India's health priorities. Discover the key trends that made wellness a daily habit and what it means for 2026.
Priya S K Sharma, an M.Pharm student at MSU Vadodara, secures the Schott Fiolax Scholarship 2025 for academic excellence in pharmaceutical chemistry. Read her inspiring story.
Pandit Bhagwat Dayal Sharma University of Health Sciences, Rohtak has published results for B.Pharmacy, GNM, and M.Pharma exams. Download official gazettes from uhsr.ac.in.
GSHSEB extends GUJCET 2026 online application deadline to January 6, 2026. Get details on exam dates, fees, and how to apply for engineering and pharmacy courses.